PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
Ovintiv Inc. (OVV)
40.910.33 (-0.80%)
40.40 - 41.05
29.80 - 47.18
2.12M / 3.66M (Avg.)
18.02 | 2.27
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
-13.71%
Both yoy net incomes decline, with BTE at -160.01%. Martin Whitman would view it as a broader sector or cyclical slump hitting profits.
17.57%
Some D&A expansion while BTE is negative at -3.30%. John Neff would see competitor’s short-term profit advantage unless expansions here deliver big returns.
80.68%
Well above BTE's 59.88% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
No Data
No Data available this quarter, please select a different quarter.
-720.43%
Negative yoy working capital usage while BTE is 199.58%. Joel Greenblatt would see more free cash if revenue remains unaffected, giving a short-term advantage.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-162.94%
Both negative yoy, with BTE at -29.28%. Martin Whitman would suspect an overall environment of intangible cleanup or shifting revaluations for the niche.
-45.29%
Negative yoy CFO while BTE is 20.29%. Joel Greenblatt would see a disadvantage in operational cash generation vs. competitor.
21.44%
Lower CapEx growth vs. BTE's 45.37%, potentially boosting near-term free cash. David Dodd would confirm no missed expansions that competitor might exploit.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-641.12%
Both yoy lines negative, with BTE at -951.43%. Martin Whitman suspects a cyclical or strategic rationale for cutting extra invests in the niche.
-226.89%
Both yoy lines negative, with BTE at -5.06%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-2582.77%
We cut debt repayment yoy while BTE is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
-61.20%
Negative yoy issuance while BTE is 0.00%. Joel Greenblatt sees a near-term advantage in avoiding dilution unless competitor invests more effectively with the new shares.
94.45%
Buyback growth of 94.45% while BTE is zero at 0.00%. Bruce Berkowitz sees a modest per-share advantage that might accumulate if the stock is below intrinsic value.